
Science & Technology
How CRISPR gene-editing is solving hemp's THC compliance problem and unlocking British hemp cultivation
Precision Breeding Quick Facts
How does Precision Plants use gene editing for hemp?
Precision Plants uses CRISPR-Cas9 to deliver multiple precision trait modifications per variety. The Stackatrait™ platform addresses five core trait categories — regulatory compliance, agronomic performance, processing quality, environmental resilience, and climate adaptation — all within a single variety. Three varieties are in development: BritGrain Auto™ (grain specialist), LongLine Fibre™ (fibre specialist), YieldMax Duo™ (dual-purpose).
The science is validated through a formal research partnership with Rothamsted Research and supported by £912,000 in DEFRA government funding. Under the Precision Breeding Act 2023, these gene-edited varieties follow a streamlined regulatory pathway in England, distinct from GMO regulation. — Precision Breeding Act 2023
Explore Our Science
Precision Plants combines cutting-edge CRISPR technology with world-class research partnerships to develop hemp varieties that are genetically incapable of exceeding THC limits.
Backed by World-Class Research
Our science is validated by leading UK institutions




The THC Compliance Problem
Hemp and marijuana are the same species (Cannabis sativa). The only legal distinction is THC content: below 0.2% = hemp (legal), above 0.2% = controlled substance.
Current EU-bred varieties were developed for continental European climates. When grown in UK conditions (longer days, cooler temperatures, variable weather), THC levels become unpredictable. 15-30% of UK hemp crops exceed legal limits, resulting in mandatory destruction and total financial loss.
Why EU Varieties Fail in the UK
EU varieties bred for warmer, drier continental conditions
UK's longer summer days trigger stress responses
Cool UK nights increase THC synthesis
Traditional breeding can't lock in low-THC traits
No British hemp genetics programme exists
Precision Breeding with Stackatrait™
Precision Plants uses CRISPR gene-editing to disable the THC synthesis pathway at the genetic level. Through our cannabinoid modification technology, we create varieties that cannot produce THC above trace levels, regardless of environmental conditions.
This isn't about suppressing THC - it's about eliminating the genetic capacity to produce it. The result: designed-in compliance, targeting every field, every season.


CRISPR Gene-Editing Technology
CRISPR-Cas9 is a revolutionary gene-editing tool that allows precise modifications to DNA. It works like molecular scissors, cutting DNA at specific locations to disable or modify genes.
Precision
multiple precision trait modifications per variety with no foreign DNA. Each edit backed by peer-reviewed research (Nature Genetics, Science, Plant Cell).
Speed
3-5 years vs 10-15 years for traditional breeding. Faster route to market-ready varieties.
Safety
No transgenic material. Regulated under UK Precision Breeding Act (2023) - not GMO classification.
Natural
Creates changes that could occur naturally through mutation. Accelerates evolution, doesn't replace it.
How Our Gene-Editing Works
Identify Target
Identify cannabinoid pathway responsible for THC production
Design Guide
Create guide RNA to direct CRISPR to exact location
Make Edit
CRISPR-Cas9 cuts DNA, cell repair disables gene
Validate
Confirm edit, grow plants, verify THC elimination
Precision Breeding Act 2023
The UK's Precision Breeding Act (2023) creates a clear regulatory pathway for gene-edited crops. Unlike GMOs, precision-bred organisms (PBOs) that could have occurred naturally are now regulated separately - with a streamlined approval process.

UK Legislation
Precision Breeding Act 2023

Ready to Grow the Future of
British Agriculture?
"There is only one known annually renewable natural resource… capable of providing the majority of the world's paper and textiles… energy needs, while simultaneously reducing pollution… and that substance is… Cannabis hemp."
Join our farm trial programme or register your interest for our 2032 commercial seed release.